The incidence of vitiligo and its clinical features in response to Psoralen group of drugs and associated other diseases

Journal Title: IP Indian Journal of Clinical and Experimental Dermatology - Year 2016, Vol 2, Issue 3

Abstract

Background: Vitiligo incidence and treatment modalities are diverse and remain unsatisfactory. There is high incidence of vitiligo among patients suffering from systemic disorders. Aim: The present study was undertaken to study the incidence of vitiligo and its response to psoralen group of drugs and association with other diseases. Methodology: 150 patients attending the outpatient department of Dermatology, Venereology and leprology at Chitageri General Hospital and Bapuji Hospital attached to J.J.M Medical College, Davengere were utilized for the current to study clinical features in response to psoralen group drugs in vitiligo and its association with other diseases. Results: The incidence of vitiligo was at around 1.49% in the present study. The localized type was 46.7% and spread type 14% and vulgaris type 2.7% was observed in the current study. Among 50 cases which were studied with psoralen groups of drugs; vitiligo repigmentation occurred in 11 patients treated with 8-Methoxy Psoralen (8MOP) and 1 patient treated with Tri-methyl Psoralen (TMP) and 2 patients treated with Psoralen alone in the present study was recorded. 5 patients out of 130 were associated with other diseases of 2 with Diabetes mellitus, 1 each of Psoriasis, alopecia areata and borderline tuberculoid leprosy observed in the present study. Conclusion: Awareness should be given to the vitiligo patients on its incidence, type and role of psoralen drugs in treatment. Psoralen group drugs could give better results in treatment of vitiligo than other drugs.

Authors and Affiliations

Girish V. Nagaral, Karibasappa Karibasappa

Keywords

Related Articles

Patterned wound healing effect of topical recombinant human epidermal growth factor in trophic ulcers secondary to leprosy

The aim of this study was to evaluate the wound healing effect of topical recombinant human Epidermal Growth Factor Rh EGF in trophic ulcers in leprosy patients 40 patients 29 males and 11 females were included in the st...

Favre-racouchot syndrome: Case report

It is also known as nodular elastosis with cyst and comedones The pathophysiology of disease causation is unknown the condition may arises due to prolonged sun exposure We report a case of 68 year old male agriculturist...

Early Androgenetic Alopecia and Insulin Resistance- A case control study

Background: In Androgenetic alopecia AGA, androgens induce miniaturization of hair follicles in those genetically predisposed to baldness. The previously known association between Androgenetic Alopecia AGA and cardiovasc...

The incidence of vitiligo and its clinical features in response to Psoralen group of drugs and associated other diseases

Background: Vitiligo incidence and treatment modalities are diverse and remain unsatisfactory. There is high incidence of vitiligo among patients suffering from systemic disorders. Aim: The present study was undertaken t...

Comparative Study of Oral Acyclovir and Oral Famciclovir in the treatment of Herpes Zoster

Abstract Background: Herpes zoster is a common viral infection, mostly affect elderly and immune compromised patients. Specific treatment includes antivirals. Most commonly used drug is acyclovir. Material and Methods: O...

Download PDF file
  • EP ID EP243523
  • DOI -
  • Views 84
  • Downloads 0

How To Cite

Girish V. Nagaral, Karibasappa Karibasappa (2016). The incidence of vitiligo and its clinical features in response to Psoralen group of drugs and associated other diseases. IP Indian Journal of Clinical and Experimental Dermatology, 2(3), 102-105. https://europub.co.uk/articles/-A-243523